Screener
ADMA Biologics ADMA Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: ADMA Biologics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:16 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001140361-26-031445
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Inventories, net | 239,313 | 206,465 |
| Prepaid expenses and other current assets | 14,639 | 7,458 |
| Assets held for sale | - | 6,530 |
| Total current assets | 528,203 | 466,512 |
| Property and equipment, net | 66,664 | 65,057 |
| Intangible assets, net | 575 | 632 |
| Goodwill | 3,530 | 3,530 |
| Deferred tax assets, net | 69,965 | 73,261 |
Item 1. Financial Statements.
FAQ
- What is ADMA Biologics's total current assets?
- ADMA Biologics (ADMA) reported total current assets of $528.2M in Q2 2026.
- How has ADMA Biologics's total current assets changed year-over-year?
- ADMA Biologics's total current assets increased by 32.2% year-over-year, from $399.56M to $528.2M.
- What is the long-term trend for ADMA Biologics's total current assets?
- Over 5 years (2020 to 2025), ADMA Biologics's total current assets has grown at a 24.9% compound annual growth rate (CAGR), from $153.74M to $466.51M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about ADMA Biologics's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude